Probiotics in digestive, emotional, and pain-related disorders
View/ Open
Impact
Scholar |
Other documents of the author: Roman, Pablo; Abalo, Raquel; Marco, Eva, M.; Cardona, Diana
Metadata
Show full item recordcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/36084
comunitat-uji-handle3:10234/36085
comunitat-uji-handle4:
INVESTIGACIONMetadata
Title
Probiotics in digestive, emotional, and pain-related disordersDate
2018-04Publisher
Lippincott, Williams & WilkinsBibliographic citation
ROMAN, Pablo, et al. Probiotics in digestive, emotional, and pain-related disorders. Behavioural Pharmacology, 2018, vol. 29, no 2 and 3-Special Issue, p. 103-119Type
info:eu-repo/semantics/articlePublisher version
https://journals.lww.com/behaviouralpharm/Abstract/2018/04000/Probiotics_in_dige ...Version
info:eu-repo/semantics/submittedVersionSubject
Abstract
In recent years, interest in the relationship between gut microbiota and disease states has grown considerably. Indeed, several strategies have been employed to modify the microbiome through the administration of ... [+]
In recent years, interest in the relationship between gut microbiota and disease states has grown considerably. Indeed, several strategies have been employed to modify the microbiome through the administration of different diets, by the administration of antibiotics or probiotics, or even by transplantation of feces. In the present manuscript, we focus specifically on the potential application of probiotics, which seem to be a safe strategy, in the management of digestive, pain, and emotional disorders. We present evidence from animal models and human studies, notwithstanding that translation to clinic still deserves further investigation. The microbiome influences gut functions as well as neurological activity by a variety of mechanisms, which are also discussed. The design and performance of larger trials is urgently needed to verify whether these new strategies might be useful not only for the treatment of disorders affecting the gastrointestinal tract but also in the management of emotional and pain disorders not directly related to the gut. [-]
Is part of
Behavioural Pharmacology, 2018, vol. 29, no 2 and 3-Special IssueRights
Copyright © Wolters Kluwer Health, Inc.
http://rightsstatements.org/vocab/InC/1.0/
info:eu-repo/semantics/openAccess
http://rightsstatements.org/vocab/InC/1.0/
info:eu-repo/semantics/openAccess
This item appears in the folowing collection(s)
- INF_Articles [274]